Article
The Fontan Dapagliflozin Pilot Study (FonDap)
2026-06-26
Abstract excerpt
<h4>Background</h4> Patients with Fontan are prone to sequelae related to chronic elevations in central venous pressures. Interventions that improve venous pressures without compromising ventricular filling may therefore be of benefit. <h4>Methods</h4> We conducted a multi-center, open label, single arm pilot study of 4 weeks of dapagliflozin 10mg in adult patients with Fontan. The primary outcome was change in...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3131bce0-6a24-5f09-b147-ba73d1d9dace
- DOI
- 10.64898/2026.06.23.26356392
